2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents

Details for Australian Patent Application No. 2001285196 (hide)

Owner Allergan, Inc.

Inventors Burk, Robert M

Agent Davies Collison Cave

Pub. Number AU-B-2001285196

PCT Pub. Number WO02/26704

Priority 09671492 27.09.00 US

Filing date 22 August 2001

Wipo publication date 8 April 2002

Acceptance publication date 2 February 2006

International Classifications

C07C 405/00 (2006.01) Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

Event Publications

2 February 2006 Application Accepted

  Published as AU-B-2001285196

1 June 2006 Standard Patent Sealed

9 November 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 04 May 2006

26 April 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001285197

2001285195